Synovus Financial’s Precigen PGEN Stock Holding History

Synovus Financial’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$147K	Sell	44,690 -4,375	-9%	-$12.4K	﹤0.01%	923
2025 Q2	$69.7K	Hold	49,065	–	–	﹤0.01%	903
2025 Q1	$73.1K	Hold	49,065	–	–	﹤0.01%	884
2024 Q4	$55K	Sell	49,065 -49,065	-50%	-$41.9K	﹤0.01%	863
2024 Q3	$92.9K	Buy	98,130 +49,065	+100%	+$61.9K	﹤0.01%	896
2024 Q2	$77.5K	Hold	49,065	–	–	﹤0.01%	833
2024 Q1	$71.1K	Hold	49,065	–	–	﹤0.01%	836
2023 Q4	$65.7K	Hold	49,065	–	–	﹤0.01%	813
2023 Q3	$69.7K	Sell	49,065 -55,000	-53%	-$78K	﹤0.01%	825
2023 Q2	$120K	Hold	104,065	–	–	﹤0.01%	820
2023 Q1	$110K	Buy	104,065 +55,000	+112%	+$79.3K	﹤0.01%	808
2022 Q4	$74.6K	Hold	49,065	–	–	﹤0.01%	841
2022 Q3	$104K	Buy	49,065 +5,000	+11%	+$10.5K	﹤0.01%	825
2022 Q2	$59K	Sell	44,065 -7,625	-15%	-$11.3K	﹤0.01%	830
2022 Q1	$109K	Buy	51,690 +12,000	+30%	+$29.2K	﹤0.01%	828
2021 Q4	$147K	Buy	39,690 +9,800	+33%	+$42.2K	﹤0.01%	840
2021 Q3	$149K	Hold	29,890	–	–	﹤0.01%	820
2021 Q2	$195K	Hold	29,890	–	–	﹤0.01%	807
2021 Q1	$206K	Buy	+29,890	New	+$253K	﹤0.01%	717
2020 Q1	–	Sell	-1,000	Closed	-$5K	–	2204
2019 Q4	$5K	Sell	1,000 -3,000	-75%	-$16.9K	﹤0.01%	1313
2019 Q3	$23K	Hold	4,000	–	–	﹤0.01%	1062
2019 Q2	$31K	Sell	4,000 -18,188	-82%	-$97.9K	﹤0.01%	931
2019 Q1	$116K	Hold	22,188	–	–	﹤0.01%	673
2018 Q4	$146K	Hold	22,188	–	–	﹤0.01%	612
2018 Q3	$382K	Hold	22,188	–	–	0.01%	492
2018 Q2	$309K	Hold	22,188	–	–	0.01%	505
2018 Q1	$340K	Sell	22,188 -10,000	-31%	-$143K	0.01%	482
2017 Q4	$371K	Sell	32,188 -1,225	-4%	-$18.2K	0.01%	462
2017 Q3	$635K	Sell	33,413 -200	-0.6%	-$4.12K	0.01%	371
2017 Q2	$810K	Buy	33,613 +200	+0.6%	+$4.39K	0.02%	332
2017 Q1	$662K	Sell	33,413 -301	-0.9%	-$6.72K	0.01%	319
2016 Q4	$812K	Buy	+33,714	New	+$938K	0.02%	287

Other funds holding PGEN

PCM

Patient Capital Management Baltimore, Maryland $3.05B AUM 42.09% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

OCM

Occam Crest Management Darien, Connecticut $193M AUM 233.09% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Synovus Financial's PGEN Position: Q3 2025 in Review

Synovus Financial reduced its Precigen (PGEN) stake by 8.9% in Q3 2025, selling an estimated $12.4K and leaving 44,690 shares worth $147K. The position accounts for ﹤0.01% of the portfolio, ranked #923.

Synovus Financial first reported a position in PGEN in Q4 2016 and has held it in 32 quarters since. The position peaked at $812K in Q4 2016. 167 funds tracked by Wall St. Rank hold PGEN as of Q3 2025.

Synovus Financial held 44,690 shares of Precigen worth $147K as of Q3 2025.
Synovus Financial sold 4,375 Precigen shares in Q3 2025, an estimated $12.4K.
Precigen made up ﹤0.01% of Synovus Financial's portfolio in Q3 2025, its #923 holding.
Synovus Financial first reported a position in Precigen in Q4 2016 and has held it in 32 quarters since.
Synovus Financial's Precigen position peaked at $812K in Q4 2016.
167 funds tracked by Wall St. Rank held Precigen as of Q3 2025.

Based on Synovus Financial's 13F filing for Q3 2025, filed 7 Nov 2025.